These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 361531)

  • 1. Catecholamine-induced changes in plasma glucose, glucagon and insulin in rabbits: effects of somatostatin.
    Potter DE; Barnett JW; Woodson LC
    Horm Metab Res; 1978 Sep; 10(5):373-7. PubMed ID: 361531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of endogenous glucagon release on hyperglycemic responses to catecholamines in normal fed and diabetic rats.
    Woodson LC; Potter DE
    J Pharmacol Exp Ther; 1979 Sep; 210(3):458-64. PubMed ID: 480194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine-induced hyperglycemia in dogs: independence from alterations in pancreatic hormone release.
    Woodson LC; Bee DE; Potter DE
    Horm Metab Res; 1980 Sep; 12(9):434-9. PubMed ID: 6107269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment.
    Potter DE; Ellis S
    J Pharmacol Exp Ther; 1975 May; 193(2):576-84. PubMed ID: 1142106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute in vivo stimulatory effects of human pituitary lipid-mobilizing factor on plasma levels of glucagon and insulin in rabbits.
    Knudtzon J; Winsnes A; Oyasaeter S; Foss I; Trygstad O
    Horm Metab Res; 1984 Dec; 16 Suppl 1():1-6. PubMed ID: 6398246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
    Knudtzon J
    Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons.
    Woodson LC; Kempen RR; Bee DE; Potter DE
    Pharmacology; 1978; 17(4):221-6. PubMed ID: 99754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on basal and arginine-stimulated plasma levels of glucose, insulin and glucagon in fasted unanesthetized rabbits.
    Potter DE; Morris JW
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):180-6. PubMed ID: 7002081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
    Eigler N; Saccà L; Sherwin RS
    J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine-induced changes in plasma glucose and insulin levels in the unanesthetized rabbit.
    Moratinos J; Ellis S; Potter DE
    Pharmacology; 1977; 15(5):407-14. PubMed ID: 918144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
    Knudtzon J
    Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW; Goodner CJ; Koerker DJ; Johnson DG; Ensinck JW
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure to glucagon impairs glucose recovery after insulin-induced hypoglycemia in man.
    Clausen N; Adamson U; Lins PE
    Horm Metab Res; 1987 Aug; 19(8):375-8. PubMed ID: 2889657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucoregulatory hormones in the immobilization stress-induced increase of plasma glucose in fasted and fed rats.
    Yamada F; Inoue S; Saitoh T; Tanaka K; Satoh S; Takamura Y
    Endocrinology; 1993 May; 132(5):2199-205. PubMed ID: 8477665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.